chr22-37738702-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001039141.3(TRIOBP):c.5167C>A(p.Gln1723Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000183 in 1,613,908 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001039141.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRIOBP | NM_001039141.3 | c.5167C>A | p.Gln1723Lys | missense_variant | 10/24 | ENST00000644935.1 | NP_001034230.1 | |
LOC124905115 | XM_047441691.1 | c.*843G>T | 3_prime_UTR_variant | 3/3 | XP_047297647.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRIOBP | ENST00000644935.1 | c.5167C>A | p.Gln1723Lys | missense_variant | 10/24 | NM_001039141.3 | ENSP00000496394 | A2 | ||
TRIOBP | ENST00000344404.10 | c.*4650C>A | 3_prime_UTR_variant, NMD_transcript_variant | 8/22 | 2 | ENSP00000340312 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152032Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000140 AC: 35AN: 249236Hom.: 0 AF XY: 0.000155 AC XY: 21AN XY: 135332
GnomAD4 exome AF: 0.000184 AC: 269AN: 1461758Hom.: 0 Cov.: 31 AF XY: 0.000186 AC XY: 135AN XY: 727174
GnomAD4 genome AF: 0.000171 AC: 26AN: 152150Hom.: 0 Cov.: 31 AF XY: 0.000121 AC XY: 9AN XY: 74394
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Oct 23, 2015 | Variant classified as Uncertain Significance - Favor Benign. The p.Gln1723Lys va riant in TRIOBP has not been previously reported in individuals with hearing los s, but has been identified in 18/65700 of European chromosomes by the Exome Aggr egation Consortium (ExAC, http://exac.broadinstitute.org;rs370224413). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. Computational prediction tools and conserv ation analyses suggest that the p.Gln1723Lys variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, the clinical significance of the p.Gln1723Lys variant is uncertain. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 14, 2019 | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 27605359) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at